To study the efficacy of pippalyadi churna in the management of Allergic bronchitis

A comparativw clinical study to evaluate the therapeutic effect of pippalyadi churna and sitophaladi churna in the management of kaphaja kasa VIS-A-VIS Allergic bronchitis - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082804

Enrollment

Registered

2025-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J411- Mucopurulent chronic bronchitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical symptoms of kaphaja kasa bahula, madhura, shwet snigdha, nishtiva, ghana kapha, gourava, aruchi, shirashoola, swarabheda, peenasa, utklesha, mandagni Patients aged between 20-60 years of either gender. Allergic bronchitis ranges from mild to moderate

Exclusion criteria

Exclusion criteria: Diagnosed patients with DM/HTN Diagnosed patients with Emphysema,CHD, Pnuemothorax, Septicemia, Haemoptysis, pneumonia, TB, Interstitial lung diseases Pregnant women and lactating mother Diagnosed patients with covid-19

Design outcomes

Primary

Measure	Time frame
To reduce the respiratory complaintsTimepoint: 15 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Bhuvaneshwari

Muniyal institute of ayurveda medical sciences, Manipal

pramodshetb@gmail.com7204557179

Outcome results